---
title: "Hengrui Pharma: Net profit in the third quarter was 1.3 billion yuan, a year-on-year increase of 9.53%; net profit in the first three quarters was 5.75 billion yuan, a year-on-year increase of 24.50%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262856489.md"
description: "Hengrui Pharma's net profit for the third quarter was 1.3 billion yuan, a year-on-year increase of 9.53%; the net profit for the first three quarters was 5.75 billion yuan, a year-on-year increase of 24.50%"
datetime: "2025-10-27T09:35:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262856489.md)
  - [en](https://longbridge.com/en/news/262856489.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262856489.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/262856489.md) | [繁體中文](https://longbridge.com/zh-HK/news/262856489.md)


# Hengrui Pharma: Net profit in the third quarter was 1.3 billion yuan, a year-on-year increase of 9.53%; net profit in the first three quarters was 5.75 billion yuan, a year-on-year increase of 24.50%

Hengrui Pharma: The net profit for the third quarter is 1.3 billion yuan, a year-on-year increase of 9.53%; the net profit for the first three quarters is 5.75 billion yuan, a year-on-year increase of 24.50%.

Risk Warning and Disclaimer

The market has risks, and investment requires caution. This article does not constitute personal investment advice and does not take into account the specific investment goals, financial conditions, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment based on this is at one's own risk

### Related Stocks

- [Hengrui Pharma (600276.CN)](https://longbridge.com/en/quote/600276.CN.md)
- [HENGRUI PHARMA (01276.HK)](https://longbridge.com/en/quote/01276.HK.md)

## Related News & Research

- [Chinese company to use AI-powered testing to boost profits and fast-track IVF](https://longbridge.com/en/news/280950532.md)
- [Fosun Pharmaceutical to Set Up Parallel Fund Structure](https://longbridge.com/en/news/281297569.md)
- [CICC Sticks to Its Buy Rating for CIMC Enric Holdings (CIMEF)](https://longbridge.com/en/news/281132485.md)
- [In pursuit of profit, India Inc slows R&D as innovation takes back seat](https://longbridge.com/en/news/281098039.md)
- [InnoCare Hits Profit Milestone, Relative Undervaluation Points To Stock Upside](https://longbridge.com/en/news/280994733.md)